Quantcast

DrugRisk Alert: Judge Calls For Census of NuvaRing Lawsuits as Trial Delayed

October 30, 2013

The Drug Risk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com

Kansas City, MO (PRWEB) October 30, 2013

The birth control safety advocates at DrugRisk.com are announcing updated information for women using the contraceptive NuvaRing. A judge overseeing a growing number of lawsuits alleging the device caused blood clots recently postponed the start of trials as the court determines how many claims are expected*.

DrugRisk is a free resource for those taking popular prescription drugs. By learning about the latest product recalls, safety alerts, research and litigation news, patients can avoid dangerous drugs, see if others are experiencing similar side effects and decide if they need legal advice.

The resource center has added warnings from health experts linking contraceptives like NuvaRing to higher risks of blood clots than traditional birth control pills. Last year, the New England Journal of Medicine published a study finding vaginal ring contraceptives could relate to a 2.5 to 3-fold increased risk of blood clots**.

Due to the number of patients who’ve filed a NuvaRing lawsuit alleging blood clots, many cases were consolidated in a special federal multidistrict litigation court in Missouri. The formal case is In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri. The latest court records show the number of cases has grown to 1,502 as of October 17***.

Now, DrugRisk has learned that U.S. District Judge Rodney Sippel, who is overseeing the litigation, had postponed the first trial from January 27th to April 7, 2014*. He also asked that all counsel provide a census of anticipated cases****.

DrugRisk notes that the census could be a court management tactic to prepare for coming trials or could be a way to facilitate a mass settlement between parties.

Anyone who suffered a blood clot, stroke, DVT or pulmonary embolism after using NuvaRing is urged to contact the DrugRisk Center or speak with a lawyer about their legal rights as soon as possible. However, DrugRisk only recommends lawyers and law firms who have already handled NuvaRing lawsuits.

For more information on the research, side effects and litigation news related to NuvaRing and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*U.S. District Judge Rodney Sippel, 10/8/13; aboutlawsuits.com/wp-content/uploads/2013-10-08-NuvaRing-Order.pdf

**New England Journal of Medicine, 6/14/12; nejm.org/doi/full/10.1056/NEJMoa1111840

***Judicial Panel on Multidistrict Litigation, 10/17/13; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-October-17-2013.pdf

****U.S. District Judge Rodney Sippel, 10/8/13; aboutlawsuits.com/wp-content/uploads/2013-10-08-NuvaRing-CMO.pdf

For the original version on PRWeb visit: http://www.prweb.com/releases/nuvaring-blood-clot/lawsuit-information/prweb11285280.htm


Source: prweb



comments powered by Disqus